THE SIGNIFICANCE OF FAST DIAGNOSTICS OF SARS-COV-2, GOOD HEALTH CARE ORGANIZATION AND REASONABLE USE OF KNOWLEDGE AND RESOURCES IN THE FIGHT AGAINST COVID-19

  • Valentina Arsic Arsenijevic Institute of Microbiology and Immunology, Faculty of Medicine University of Belgrade, Belgrade, Serbia
  • Miha Skvarc General Hospital Jesenice, Jesenice, Slovenia
Keywords: Covid-19, SARS-CoV-2, microbiological diagnostics, health care workers, knowledge, resources

Abstract


In December 2019, a new disease appeared, that is, pneumonia of unknown cause, which was linked
to a seafood market in Wuhan (China). Human respiratory epithelial cells were used to isolate a novel
coronavirus, named according to the clinical picture “Severe Acute Respiratory Syndrome Coronavirus 2”
(SARS-CoV-2), whereas the disease was named the coronavirus disease 2019 (Covid-19). This pandemic
has proved to be a great challenge for all professionals dealing with microbiological diagnostics, as well
as for all health care workers. The aim of this work is to present the significance of fast diagnostics of
SARS-CoV-2, the significance of protection of health of health care workers, and the reasonable use
of knowledge and resources in the fight against Covid-19. The previous research has confirmed that
in the fight against the SARS-Cov-2 infection, fast diagnostics of SARS-CoV-2, protection of health of
health care workers and reasonable use of knowledge and resources during the pandemic are of utmost
importance. A special emphasis is put on the vaccination against seasonal influenza, as well as against
the invasive pneumococcal disease because, with the help of these vaccines, the diagnosis of Covid-19
could be made easier in the future period, in which the efficient antiviral therapy for SARS-CoV-2 and
the vaccine for Covid-19 are expected with great hopes.

References

European Centre for Disease Prevention and Control.

An agency of the European Union. Diagnostic testing

and screening for SARS-CoV-2. [Internet] Available

at: https://www.ecdc.europa.eu/en/covid-19/latestevidence/

diagnostic-testing [Accessed 3rd Apr 2020]

Coronaviridae Study Group of the International

Committee on Taxonomy of Viruses. The species

Severe acute respiratory syndrome-related

coronavirus: classifying 2019-nCoV and naming it

SARS-CoV-2. Nat Microbiol 2020; 5(4):536-544.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A

novel coronavirus from patients with pneumonia in

China, 2019. N Engl J Med 2020; 382(8):727-33.

WHO. Coronavirus disease 2019 (COVID-19) situation

reports. [Internet] Available at: https://www.who.

int/emergencies/diseases/novel-coronavirus-2019/

situation-reports[Accessed 3rd Apr 2020)

Dong E, Du H, Gardner L. An interactive web-based

dashboard to track COVID-19 in real time. Lancet

Infect Dis 2020; 20(5):P533-534.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course

and risk factors for mortality of adult inpatients with

COVID-19 in Wuhan, China: a retrospective cohort

study. Lancet 2020; pii: S0140-6736(20)30566-3.

Remuzzi A, Remuzzi G. COVID-19 and Italy: what

next? Lancet 2020; 395(10231):P1225-28.

Guan W, Liang W, Zhao Y, Liang, Chen Z, Li Y, et al.

Comorbidity and its impact on 1590 patients with

Covid-19 in China: A Nationwide Analysis. Eur Respir

J 2020; 55(5):2000547.

Yu J, Ouyang W, Chua M, Xie C. SARS-CoV-2

Transmission in Patients With Cancer at a Tertiary

Care Hospital in Wuhan, China. JAMA Oncol 2020;

(7):1108-10.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al.

Cancer patients in SARS-CoV-2 infection: a nationwide

analysis in China. Lancet Oncol 2020; 21(3):335-337.

Nalla AK, Casto AM, Huang MW, Perchetti GA, Sampoleo

R, Shrestha L, et al. Comparative Performance of

SARS-CoV-2 Detection Assays using Seven Different

Primer/Probe Sets and One Assay Kit. J Clin Microbiol

; 58(6):e00557-20.

Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q,

et al. The emergence of a novel coronavirus (SARSCoV-

, their biology and therapeutic options. J Clin

Microbiol 2020; 58(5):e00187-20.

Alhazzani W, Møller MH, Arabi YM, Loeb M, Ng Gong

M, Fan E, et al. Surviving Sepsis Campaign: guidelines

on the management of critically ill adults with

Coronavirus Disease 2019 (COVID-19) Intensive Care

Med 2020; 46: 854-87.

ECDC. Novel coronavirus (SARS-CoV-2) - Discharge

criteria for confirmed COVID-19 cases. [Internet]

Available at: https://www.ecdc.europa.eu/sites/

default/files/documents/COVID-19-Dischargecriteria.

pdf [Accessed 3rd Apr 2020].

Wölfel R, Corman VM, Guggemos W, Seilmaier M,

Zange S, Müller MA, et al. Virological assessment of

hospitalized patients with COVID-2019. Nature. 2020;

:465-69. doi: 10.1038/s41586-020-2196-x.

Nickel CH, Bingisser R. Mimics and chameleons of

COVID-19. Swiss Med Wkly. 2020; 150:w20231.

Michael J. Loeffelholz, Yi-Wei Tang. Laboratory

diagnosis of emerging human coronavirus infections

– the state of the art. Emerging Microbes & Infections

; 1:747-56.

Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality

of Respiratory Viral Infections. Annu Rev Virol 2020;

:386-390.

FDA. Emergency Use Authorization. In Vitro

Diagnostics EUAs. [Internet] Available at: https://

www.fda.gov/medical-devices/emergencysituations-

medical-devices/emergency-useauthorizations#

covid19ivd [Accessed 3rd Apr 2020]

NHS England. Clinical guide for the management of

noncoronavirus patients requiring acute treatment:

Cancer. 23 March 2020 Version 2. Available at:

https://www.england.nhs.uk/coronavirus/wpcontent/

uploads/sites/52/2020/03/specialtyguide-

acute-treatment-cancer-23-march-2020.pdf

[Accessed 3rd Apr 2020]

van Doremalen N, Bushmaker T, Morris DH, Holbrook

MG, Gamble A, Williamson BN, et al. Aerosol and

Surface Stability of SARS-CoV-2 as Compared with

SARS-CoV-1. N Engl J Med 2020; 382:1564-67.

Haveri A, Smura T, Kuivanen S, Österlund P, Hepojoki

J, Ikonen N, et al. Serological and molecular findings

during SARS-CoV-2 infection: the first case study in

Finland, January to February 2020. Euro Surveill

; 25(11): pii=2000266.

Emanuel EJ, Persad G, Upshur R, Thome B, Parker M,

Glickman A, et al. Fair Allocation of Scarce Medical

Resources in the Time of Covid-19. N Engl J Med.

; 382:2049-55.

Krause PJ, Gross PA, Barrett TL, Dellinger EP, Martone

WJ, McGowan JE Jr, et al. Quality standard for

assurance of measles immunity among health care

workers. The Infectious Diseases Society of America.

Infect Control Hosp Epidemiol 1994; 15(3):193-9.

Koo JR, Cook AR, Park M, Sun Y, Sun H, Lim JT, et al.

Interventions to mitigate early spread of SARS-CoV-2

in Singapore: a modelling study. Lancet Infect Dis

; 20(6):P678-688.

Hall LH, Johnson J, Watt I, Tsipa A, O'Connor DB.

Healthcare Staff Wellbeing, Burnout, and Patient

Safety: A Systematic Review. PLoS One 2016;

(7):e0159015.

Burton A, Burgess C, Dean S, Koutsopoulou GZ,

Hugh-Jones S. How Effective are Mindfulness-Based

Interventions for Reducing Stress Among Healthcare

Professionals? A Systematic Review and Meta-

Analysis. Stress Health 2017; 33(1):3-13.

Published
2020/10/20
Section
ACTUAL TOPIC